Search Results - "Campbell, Jonathan D"

Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study by Price, David B, Prof, Rigazio, Anna, MSc, Campbell, Jonathan D, PhD, Bleecker, Eugene R, MD, Corrigan, Christopher J, PhD, Thomas, Mike, PhD, Wenzel, Sally E, MD, Wilson, Andrew M, MD, Small, Mary Buatti, MS, Gopalan, Gokul, MD, Ashton, Valerie L, PhD, Burden, Anne, MSc, Hillyer, Elizabeth V, DVM, Kerkhof, Marjan, PhD, Pavord, Ian D, FMedSci

“…Summary Background Elevated sputum eosinophil counts predict asthma exacerbations and responsiveness to inhaled corticosteroids but are impractical to measure…”
Get full text

Cost-Effectiveness of Biological Asthma Treatments: A Systematic Review and Recommendations for Future Economic Evaluations by McQueen, R. Brett, Sheehan, Danielle N., Whittington, Melanie D., van Boven, Job F. M., Campbell, Jonathan D.

“…Background Recently developed asthma biological therapies have been shown to provide relief for severe asthma patients not controlled by inhaled treatment…”
Get full text

Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis by Whittington, Melanie D., MS, McQueen, R. Brett, PhD, Ollendorf, Daniel A., PhD, Tice, Jeffrey A., MD, Chapman, Richard H., PhD, MS, Pearson, Steven D., MD, MSc, Campbell, Jonathan D., PhD

“…Abstract Background Adding mepolizumab to standard treatment with inhaled corticosteroids and controller medications could decrease asthma exacerbations and…”
Get full text

Cost-Effectiveness of Patent Foramen Ovale Closure Versus Medical Therapy for Secondary Stroke Prevention by Leppert, Michelle H, Poisson, Sharon N, Carroll, John D, Thaler, David E, Kim, Chong H, Orjuela, Karen D, Ho, P Michael, Burke, James F, Campbell, Jonathan D

“…BACKGROUND AND PURPOSE—Percutaneous transcatheter closure of patent foramen ovale (PFO closure) plus antiplatelet therapy has been shown to reduce the risk of…”
Get full text

The promise of Immuno-oncology: implications for defining the value of cancer treatment by Kaufman, Howard L, Atkins, Michael B, Subedi, Prasun, Wu, James, Chambers, James, Joseph Mattingly, 2nd, T, Campbell, Jonathan D, Allen, Jeff, Ferris, Andrea E, Schilsky, Richard L, Danielson, Daniel, Lichtenfeld, J Leonard, House, Linda, Selig, Wendy K D

“…The rapid development of immuno-oncology (I-O) therapies for multiple types of cancer has transformed the cancer treatment landscape and brightened the…”
Get full text

Asthma outcomes: Healthcare utilization and costs by Akinbami, Lara J., MD, Sullivan, Sean D., PhD, MSc, Campbell, Jonathan D., PhD, MS, Grundmeier, Robert W., MD, Hartert, Tina V., MD, MPH, Lee, Todd A., PharmD, PhD, Smith, Robert A., PhD

“…Background Measures of healthcare utilization and indirect impact of asthma morbidity are used to assess clinical interventions and estimate cost. Objective…”
Get full text

Patient and Payer Preferences for Additional Value Criteria by Jakab, Ivett, Whittington, Melanie D., Franklin, Elizabeth, Raiola, Susan, Campbell, Jonathan D., Kaló, Zoltán, McQueen, R. Brett

“…Background: Defining the value of healthcare is an elusive target, and depends heavily on the decision context and stakeholders involved. Cost-utility analysis…”
Get full text

Outcomes before and after treatment escalation to Global Initiative for Asthma steps 4 and 5 in severe asthma by Sullivan, Patrick W., PhD, Campbell, Jonathan D., PhD, Ghushchyan, Vahram H., PhD, Globe, Gary, PhD, MBA

“…Abstract Background Little is known about health outcomes in severe asthma reflected by Global Initiative for Asthma steps 4 and 5. Objective To analyze…”
Get full text

Exploring asthma control cutoffs and economic outcomes using the Asthma Control Questionnaire by Sullivan, Patrick W., PhD, Globe, Gary, PhD, Ghushchyan, Vahram H., PhD, Campbell, Jonathan D., PhD, Bender, Bruce, PhD, Magid, David J., MD, MPH

“…Abstract Background Understanding the effect of worsening asthma control on expenditures and health resource utilization (HRU) is important. Objective To…”
Get full text

Measuring the effect of asthma control on exacerbations and health resource use by Sullivan, Patrick W., PhD, Campbell, Jonathan D., PhD, Globe, Gary, PhD, Ghushchyan, Vahram H., PhD, Bender, Bruce, PhD, Schatz, Michael, MD, Chon, Yun, PhD, Woolley, J. Michael, PhD, Magid, David J., MD, MPH

“…Â Incidence rate ratio SE 95% CI P value Self-reported exacerbations (yes/no)[low *] 2.141[dagger] 0.082 1.99-2.31 <.001 HRU[double dagger] Â Â Â Â No. of…”
Get full text

Is Prevalence of Atherosclerotic Risk Factors Increasing Among Young Adults? It Depends on How You Ask by Leppert, Michelle H, Poisson, Sharon N, Sillau, Stefan H, Campbell, Jonathan D, Ho, P Michael, Burke, James F

“…Background Incidence of cardiovascular disease in young adults is unabated. Increased prevalence of self-reported atherosclerotic risk factors may be driving…”
Get full text

The REal Life EVidence AssessmeNt Tool (RELEVANT): development of a novel quality assurance asset to rate observational comparative effectiveness research studies by Campbell, Jonathan D., Perry, Robert, Papadopoulos, Nikolaos G., Krishnan, Jerry, Brusselle, Guy, Chisholm, Alison, Bjermer, Leif, Thomas, Michael, Ganse, Eric, Berge, Maarten, Quint, Jennifer, Price, David, Roche, Nicolas

“…Background Evidence from observational comparative effectiveness research (CER) is ranked below that from randomized controlled trials in traditional evidence…”
Get full text

Impact of Nonmedical Vaccine Exemption Policies on the Health and Economic Burden of Measles by Whittington, Melanie D., PhD, Kempe, Allison, MD, MPH, Dempsey, Amanda, MD, PhD, MPH, Herlihy, Rachel, MD, MPH, Campbell, Jonathan D., PhD

“…Abstract Objective Despite relatively high national vaccination coverage for measles, geographic vaccination variation exists resulting in clusters of…”
Get full text

Community Health Worker Home Visits for Medicaid-Enrolled Children With Asthma: Effects on Asthma Outcomes and Costs by Campbell, Jonathan D, Brooks, Marissa, Hosokawa, Patrick, Robinson, June, Song, Lin, Krieger, James

“…We sought to estimate the return on investment of a streamlined version of an evidence-based community health worker (CHW) asthma home visit program. We used a…”
Get full text

Screening test recommendations for methicillin-resistant Staphylococcus aureus surveillance practices: A cost-minimization analysis by Whittington, Melanie D., PhD, MS, Curtis, Donna J., MD, MPH, Atherly, Adam J., PhD, Bradley, Cathy J., PhD, Lindrooth, Richard C., PhD, Campbell, Jonathan D., PhD

“…Highlights • Rapid screening tests reduce unnecessary surveillance costs. • Using polymerase chain reaction with universal preemptive isolation minimizes total…”
Get full text

Quality standards in respiratory real‐life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group—European Academy of Allergy and Clinical Immunology Task Force by Roche, Nicolas, Campbell, Jonathan D., Krishnan, Jerry A., Brusselle, Guy, Chisholm, Alison, Bjermer, Leif, Thomas, Mike, Ganse, Eric, Berge, Maarten, Christoff, George, Quint, Jennifer, Papadopoulos, Nikolaos G., Price, David

“…Introduction A Task Force was commissioned jointly by the European Academy of Allergy and Clinical Immunology (EAACI) and the Respiratory Effectiveness Group…”
Get full text

Programmatic cost evaluation of nontargeted opt-out rapid HIV screening in the emergency department by Haukoos, Jason S, Campbell, Jonathan D, Conroy, Amy A, Hopkins, Emily, Bucossi, Meggan M, Sasson, Comilla, Al-Tayyib, Alia A, Thrun, Mark W

“…The Centers for Disease Control and Prevention recommends nontargeted opt-out HIV screening in healthcare settings. Cost effectiveness is critical when…”
Get full text

Societal Implications of Health Insurance Coverage for Medically Necessary Services in the U.S. Transgender Population: A Cost-Effectiveness Analysis by Padula, William V., Heru, Shiona, Campbell, Jonathan D.

“…BACKGROUND Recently, the Massachusetts Group Insurance Commission (GIC) prioritized research on the implications of a clause expressly prohibiting the denial…”
Get full text

Selective Targeting of Gain-of-Function KCNQ1 Mutations Predisposing to Atrial Fibrillation by Campbell, Courtney M, Campbell, Jonathan D, Thompson, Christopher H, Galimberti, Eleonora Savio, Darbar, Dawood, Vanoye, Carlos G, George, Alfred L

“…BACKGROUNDAtrial fibrillation is the most common sustained cardiac arrhythmia in adults. We hypothesized that gain-of-function KCNQ1 mutations previously…”
Get full text

The prevalence of MS in the United States: A population-based estimate using health claims data by Wallin, Mitchell T, Culpepper, William J, Campbell, Jonathan D, Nelson, Lorene M, Langer-Gould, Annette, Marrie, Ruth Ann, Cutter, Gary R, Kaye, Wendy E, Wagner, Laurie, Tremlett, Helen, Buka, Stephen L, Dilokthornsakul, Piyameth, Topol, Barbara, Chen, Lie H, LaRocca, Nicholas G

“…OBJECTIVETo generate a national multiple sclerosis (MS) prevalence estimate for the United States by applying a validated algorithm to multiple administrative…”
Get full text